about
Cardiopulmonary laboratory biomarkers in the evaluation of acute dyspneaAcute coronary syndromes: pathology, diagnosis, genetics, prevention, and treatmentDiagnostic performance of reproducible chest wall tenderness to rule out acute coronary syndrome in acute chest pain: a prospective diagnostic study.Copeptin testing in acute myocardial infarction: ready for routine use?Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedsidePredictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: comments from the Dutch ACS working groupCardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin.Cardiac biomarkers for infarct diagnosis and early exclusion of acute coronary syndrome.Copeptin as a biomarker in heart failure.Biologic variability of cardiac troponin I in healthy dogs and dogs with different stages of myxomatous mitral valve disease using standard and high-sensitivity immunoassays.Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome.Heart-type fatty acid binding protein (H-FABP) in patients in an emergency department setting, suspected of acute coronary syndrome: optimal cut-off point, diagnostic value and future opportunities in primary care.An experimental model of myocardial infarction and controlled reperfusion using a miniaturized cardiopulmonary bypass in rats.High-sensitivity cardiac troponin assays: From improved analytical performance to enhanced risk stratification.Prognostic significance of transaminases after acute ST-elevation myocardial infarction: insights from a cardiac magnetic resonance study.Circulating microRNAs as potential biomarkers for coronary plaque rupture.Vascular phenotypes of acute decompensated vs. new-onset heart failure: treatment implications.Effects of B-type natriuretic peptide on cardiovascular biomarkers in healthy volunteers.Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial.Early diagnosis of acute myocardial infarction in patients with mild elevations of cardiac troponin.Early rule-out of acute coronary syndrome using undetectable levels of high sensitivity troponin T.N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study.Coronary Microembolization Induces Cardiomyocyte Apoptosis in Swine by Activating the LOX-1-Dependent Mitochondrial Pathway and Caspase-8-Dependent Pathway.Platelet extracellular vesicles as biomarkers for arterial thrombosis.Prognostic implications of high-sensitivity cardiac troponin T assay in a real-world population with non-ST-elevation acute coronary syndrome☆.The Value of Combining Plasma D-Dimer and Endothelin-1 Levels to Predict No-Reflow After Percutaneous Coronary Intervention of ST-Segment Elevation in Acute Myocardial Infarction Patients with a Type 2 Diabetes Mellitus History.Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery DiseaseDiagnostic accuracy of adding copeptin to cardiac troponin for non-ST-elevation myocardial infarction: A systematic review and meta-analysis
P2860
Q26745756-188B4D22-BCD8-4D48-8325-61870862DBFFQ33827278-B123CBB8-D3E4-404E-B501-23844432A305Q35047272-92248F84-3EA7-4B49-B09D-98A02F6AF20CQ35556651-96B8639B-7771-4802-AE58-8D7B96242021Q36371672-F4BD5B9E-E5EE-4AD7-B51C-DC7498C1C598Q37441199-8F6C7A1B-0BB2-4470-B088-F63879ADC730Q37647504-F9DC4154-183F-41E7-82DF-1309A5CA628DQ37670587-AAB1F385-75FE-4B91-A8AA-49C3B1FAF023Q38232835-ABB240AA-12F5-450D-AA0C-CAD028F0A8F7Q38249996-6EAAE921-646E-408C-B8A5-871196E76E09Q38816520-34864651-6453-48CF-B326-EE1402851D4AQ38935475-0D530546-7F00-4978-8D4B-E8AFC3E19199Q39031476-0BC54084-5CA9-4A86-8581-6DF738CC9299Q39166205-4A50AA20-B842-4C48-B9CB-1132794E2AB6Q39272975-F003A7B1-0627-49F1-8AC5-50AD38B5A24DQ40459010-D4B168E5-06E0-4155-A111-45323312E420Q41471482-F1F99923-7AEC-4108-979C-444BB04512DEQ47900509-9DBDE4FB-7570-4751-900D-17B9BD6D6050Q48400230-CEA4975B-E56F-448C-A3D4-80DBB7B957C8Q50059262-EDBB4DEA-E457-49BA-9346-A8255B802942Q50217429-FA51B375-488B-41B2-A105-1B37261B1EF1Q51046961-A23FDB9F-14D1-408A-AB1D-F5F8CE3C7856Q52585127-D6B47A37-E294-42AF-A75C-09FDAC610980Q53379067-F7EA41FA-8110-40CD-A66C-F1D43BE1C86AQ53621465-4DC423ED-D6B5-4570-91A6-4BFB57A7283BQ55278810-22940C5B-EF51-4E36-997A-514511F0EA9DQ55333688-4B1A8BFB-0715-4800-869C-4A71CC2EF34BQ56384060-7B08C818-61B4-447C-8D40-344AD8E91A06Q57101391-E0770902-7799-475B-8772-7066D874F8ED
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biomarkers and acute coronary syndromes: an update.
@en
type
label
Biomarkers and acute coronary syndromes: an update.
@en
prefLabel
Biomarkers and acute coronary syndromes: an update.
@en
P2860
P356
P1476
Biomarkers and acute coronary syndromes: an update.
@en
P2093
Christian Mueller
P2860
P304
P356
10.1093/EURHEARTJ/EHT530
P577
2013-12-18T00:00:00Z